Neuropeptide Y Protects Brain Connections in Alzheimer's Disease Through the ABCA7 Gene
The Alzheimer's risk gene ABCA7 regulates neuropeptide Y production, which is essential for maintaining brain connections through BDNF signaling — and its loss accelerates synaptic damage.
Quick Facts
What This Study Found
ABCA7 loss suppresses neuropeptide Y expression, reducing BDNF and synaptic density — a mechanism directly linking this Alzheimer's risk gene to brain resilience through NPY-BDNF-NGFR signaling.
Key Numbers
Used single-cell transcriptomics in heterozygous abca7+/- knockout zebrafish combined with Aβ42 toxicity models.
How They Did This
CRISPR-Cas9 knockout zebrafish with single-cell transcriptomics, human iPSC-derived neurons exposed to Aβ42, and clinical correlation with human AD brain samples and genetic data.
Why This Research Matters
This study reveals a concrete molecular pathway connecting one of the top Alzheimer's risk genes to brain protection, opening potential therapeutic targets through neuropeptide Y supplementation or pathway modulation.
The Bigger Picture
Understanding how genetic risk factors actually cause Alzheimer's at the molecular level is crucial for developing targeted therapies. This study suggests that boosting neuropeptide Y signaling could help maintain brain resilience in people with ABCA7 risk variants.
What This Study Doesn't Tell Us
Zebrafish and iPSC-derived neuron models may not fully recapitulate human Alzheimer's pathology; clinical correlations are observational; causal pathway in humans not yet proven through intervention studies; NPY supplementation as therapy not tested.
Questions This Raises
- ?Could intranasal or targeted NPY delivery prevent or slow synaptic loss in early Alzheimer's?
- ?Are ABCA7 variant carriers specifically responsive to NPY-boosting interventions?
- ?Does this ABCA7-NPY pathway interact with other known Alzheimer's risk pathways like APOE?
Trust & Context
- Key Stat:
- NPY rescued synapses ectopic neuropeptide Y restored synaptic density lost from ABCA7 deletion
- Evidence Grade:
- Preliminary but multi-level evidence spanning zebrafish models, human iPSC neurons, and clinical AD patient data, providing convergent support for the proposed mechanism.
- Study Age:
- Published in 2024, representing current advances in understanding Alzheimer's genetic risk mechanisms.
- Original Title:
- ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer's disease through BDNF/NGFR signaling.
- Published In:
- Cell genomics, 4(9), 100642 (2024)
- Authors:
- Tayran, Hüseyin, Yilmaz, Elanur, Bhattarai, Prabesh, Min, Yuhao, Wang, Xue, Ma, Yiyi, Wang, Ni, Jeong, Inyoung, Nelson, Nastasia, Kassara, Nada, Cosacak, Mehmet Ilyas, Dogru, Ruya Merve, Reyes-Dumeyer, Dolly, Stenersen, Jakob Mørkved, Reddy, Joseph S, Qiao, Min, Flaherty, Delaney, Gunasekaran, Tamil Iniyan, Yang, Zikun, Jurisch-Yaksi, Nathalie, Teich, Andrew F, Kanekiyo, Takahisa, Tosto, Giuseppe, Vardarajan, Badri N, İş, Özkan, Ertekin-Taner, Nilüfer, Mayeux, Richard, Kizil, Caghan
- Database ID:
- RPEP-09372
Evidence Hierarchy
Frequently Asked Questions
What does neuropeptide Y have to do with Alzheimer's disease?
NPY helps maintain healthy connections between brain cells. This study found that when the ABCA7 gene (a known Alzheimer's risk gene) is impaired, NPY production drops, leading to loss of brain connections. NPY levels also decline as Alzheimer's progresses in patients.
Could boosting neuropeptide Y prevent Alzheimer's?
It's too early to say, but the study showed that adding NPY back to brain cells with ABCA7 problems restored their synaptic connections. This suggests NPY-boosting strategies could be worth testing in future Alzheimer's prevention trials.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09372APA
Tayran, Hüseyin; Yilmaz, Elanur; Bhattarai, Prabesh; Min, Yuhao; Wang, Xue; Ma, Yiyi; Wang, Ni; Jeong, Inyoung; Nelson, Nastasia; Kassara, Nada; Cosacak, Mehmet Ilyas; Dogru, Ruya Merve; Reyes-Dumeyer, Dolly; Stenersen, Jakob Mørkved; Reddy, Joseph S; Qiao, Min; Flaherty, Delaney; Gunasekaran, Tamil Iniyan; Yang, Zikun; Jurisch-Yaksi, Nathalie; Teich, Andrew F; Kanekiyo, Takahisa; Tosto, Giuseppe; Vardarajan, Badri N; İş, Özkan; Ertekin-Taner, Nilüfer; Mayeux, Richard; Kizil, Caghan. (2024). ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer's disease through BDNF/NGFR signaling.. Cell genomics, 4(9), 100642. https://doi.org/10.1016/j.xgen.2024.100642
MLA
Tayran, Hüseyin, et al. "ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer's disease through BDNF/NGFR signaling.." Cell genomics, 2024. https://doi.org/10.1016/j.xgen.2024.100642
RethinkPeptides
RethinkPeptides Research Database. "ABCA7-dependent induction of neuropeptide Y is required for ..." RPEP-09372. Retrieved from https://rethinkpeptides.com/research/tayran-2024-abca7dependent-induction-of-neuropeptide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.